Hypha Labs, Inc. FUNI
$0.01
$0.000.00%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -50.24% | -37.04% | -29.46% | 67.15% | 121.22% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -50.24% | -37.04% | -29.46% | 67.15% | 121.22% |
| Operating Income | 50.24% | 37.04% | 29.46% | -67.15% | -121.22% |
| Income Before Tax | 36.92% | 32.17% | 10.61% | -128.68% | -188.67% |
| Income Tax Expenses | -- | -- | -- | -- | -145.38% |
| Earnings from Continuing Operations | 36.67% | 31.42% | 11.11% | -126.31% | -180.57% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -100.00% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 36.67% | 31.42% | -0.31% | -294.88% | -5,053.08% |
| EBIT | 50.24% | 37.04% | 29.46% | -67.15% | -121.22% |
| EBITDA | 50.53% | 37.39% | 13.13% | -162.92% | -358.96% |
| EPS Basic | 47.68% | 44.27% | 13.37% | -280.65% | -3,485.71% |
| Normalized Basic EPS | 49.67% | 44.44% | 42.29% | -24.58% | -46.60% |
| EPS Diluted | 47.68% | 50.68% | 26.70% | -145.83% | -777.78% |
| Normalized Diluted EPS | 49.67% | 44.44% | 42.29% | -24.58% | -46.60% |
| Average Basic Shares Outstanding | 21.90% | 23.70% | 28.19% | 33.37% | 36.68% |
| Average Diluted Shares Outstanding | 21.90% | 23.70% | 28.19% | 33.37% | 36.68% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |